About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  QUARTERLY RESULTS
Quarterly Results      
Dr. Reddy's Laboratories Ltd.
BSE Code 500124
ISIN Demat INE089A01031
Book Value 379.50
NSE Code DRREDDY
Dividend Yield % 0.63
Market Cap 1052815.36
P/E 15.27
EPS 82.59
Face Value 1  
Quarters :
(Rs. in Millions)
Particulars (Rs in Million) Jun 2025Mar 2025Dec 2024Sep 2024
 Audited / UnAudited UnAudited UnAudited UnAudited Audited
Net Sales 78095.00 55629.00 50150.00 66963.00
Total Expenditure 39725.00 41199.00 38226.00 39747.00
PBIDT (Excl OI) 38370.00 14430.00 11924.00 27216.00
Other Income 3983.00 4144.00 2354.00 2076.00
Operating Profit 42353.00 18574.00 14278.00 29292.00
Interest 192.00 311.00 433.00 284.00
Exceptional Items 0 0 0 0
PBDT 42161.00 18263.00 13845.00 29008.00
Depreciation 2798.00 2645.00 2651.00 2600.00
Profit Before Tax 39363.00 15618.00 11194.00 26408.00
Tax 9751.00 3611.00 2700.00 7587.00
Provisions and contingencies 0 0 0 0
Profit After Tax 29612.00 12007.00 8494.00 18821.00
Extraordinary Items 0 0 0 0
Prior Period Expenses 0 0 0 0
Other Adjustments 0.00 0.00 0.00 0.00
Net Profit 29612.00 12007.00 8494.00 18821.00
Equity Capital 835.00 834.00 834.00 834.00
Face Value (IN RS) 1 1 1 5
Reserves    
Calculated EPS 35.46 14.40 10.18 112.84
Calculated EPS (Annualised) 141.85 57.59 40.74 451.34
No of Public Share Holdings 520156866.00 515837296.00 501703345.00 98692523.00
% of Public Share Holdings 62.32 61.82 60.12 59.14
     
PBIDTM% (Excl OI) 49.13 25.94 23.78 40.64
PBIDTM% 54.23 33.39 28.47 43.74
PBDTM% 53.99 32.83 27.61 43.32
PBTM% 50.40 28.08 22.32 39.44
PATM% 37.92 21.58 16.94 28.11
 Notes Notes Notes Notes
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.